VVector Bio offers biomanufacturing services to accelerate the development and commercialization of novel medicines.
VVector Bio has raised $250K in total funding. The most recent round was Seed. The last funding was announced in April 2022.
VVector Bio's investors include Newchip Accelerator.
VVector Bio is headquartered in Montréal, Canada.
VVector Bio offers biomanufacturing services to accelerate the development and commercialization of novel medicines.
VVector Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VVector Bio — Funding & Investors." VCBacked, April 28, 2022, https://www.vcbacked.co/company/vvector-bio. Accessed September 13, 2026.
VCBacked. (2022). VVector Bio — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/vvector-bio
{{cite web |title=VVector Bio — Funding & Investors |url=https://www.vcbacked.co/company/vvector-bio |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated